The Claim
In aged female 3xTg mice, 7 days of istradefylline treatment is associated with a 10% improvement in spontaneous alternation in the T-maze and a 3.5-fold increase in novel object exploration, resulting in working and long-term memory performance comparable to that of healthy aged C57BL/6 mice.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In aged female mice with Alzheimer’s-like brain changes, 7 days of istradefylline treatment improved performance on memory tests, bringing their performance to the level of healthy aged mice.
See the scientific wording
In aged female 3xTg mice, 7 days of istradefylline treatment was associated with a 10% improvement in spontaneous alternation in the T-maze and a 3.5-fold increase in novel object exploration, restoring working and long-term memory performance to levels comparable to healthy aged C57BL/6 mice, suggesting that A2A receptor blockade may improve cognitive function in this Alzheimer’s model.
Blocking a specific brain receptor called A2A improves blood flow in the brain by increasing a molecule that opens blood vessels, while also reducing harmful protein buildup that damages brain cells. This fixes both the brain's oxygen supply and its cellular cleanliness, allowing memory circuits to work normally again.
What the research says
1 studyIn older female mice with Alzheimer’s-like memory issues, a drug called istradefylline helped them remember better — they could recall which path they took in a maze and recognize new objects, just like healthy mice. The drug seems to fix blood flow and brain clutter that messes up memory.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.